New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.

about

Neurodegenerative drug discovery: building on the past, looking to the future.

P2860

Q38683814-1BE92A6A-F4F2-4798-B728-C31364316A54

P2860

New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.

Item

http://www.wikidata.org/entity/Q38686081

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

New (benz)imidazolopyridino ta ...... ibitors for Alzheimer disease.

@en

type

Item

label

New (benz)imidazolopyridino ta ...... ibitors for Alzheimer disease.

@en

prefLabel

New (benz)imidazolopyridino ta ...... ibitors for Alzheimer disease.

@en

P1476

New (benz)imidazolopyridino ta ...... hibitors for Alzheimer disease

@en

P2093

Alexandre Bonet

http://www.w3.org/2001/XMLSchema#string

Ali Belfaitah

http://www.w3.org/2001/XMLSchema#string

Helene Martin

http://www.w3.org/2001/XMLSchema#string

José Marco Contelles

http://www.w3.org/2001/XMLSchema#string

Lhassane Ismaili

http://www.w3.org/2001/XMLSchema#string

Mourad Chioua

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

A new and rapid colorimetric determination of acetylcholinesterase activity

Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.

Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheime

Neuronutrition and Alzheimer's disease

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Role of metabolism in drug-induced idiosyncratic hepatotoxicity.

Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.

P304

723-729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2017-0019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Houssem Boulebd

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485637

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.

about

P2860

P2860

New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921